Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care

Background Lack of healthcare access to due to physician shortages is a significant driver of telemedicine expansion in rural areas. Telemedicine is effective for management of chronic conditions such as diabetes but its effectiveness in primary care settings is unknown. Objective To evaluate differ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of general internal medicine : JGIM 2021-09, Vol.36 (9), p.2585-2592
Hauptverfasser: Lu, Amy D., Gunzburger, Elise, Glorioso, Thomas J., Smith, William B., Kenney, Rachael R., Whooley, Mary A., Ho, P. Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2592
container_issue 9
container_start_page 2585
container_title Journal of general internal medicine : JGIM
container_volume 36
creator Lu, Amy D.
Gunzburger, Elise
Glorioso, Thomas J.
Smith, William B.
Kenney, Rachael R.
Whooley, Mary A.
Ho, P. Michael
description Background Lack of healthcare access to due to physician shortages is a significant driver of telemedicine expansion in rural areas. Telemedicine is effective for management of chronic conditions such as diabetes but its effectiveness in primary care settings is unknown. Objective To evaluate differences in diabetes care before and after implementation of a longitudinal virtual primary care program. Design Propensity score-matched cohort study utilizing difference-in-differences analysis. Participants Patients with diabetes who received care at VA primary care clinics between January 2018 and December 2019 where the Virtual Integrated Multisite Patient Aligned Care Teams (V-IMPACT) program was implemented. Exposure Patient participation in at least one V-IMPACT visit while usual care patients did not participate in V-IMPACT. Main Measures The primary outcome was change in hemoglobin A1C (HbA1C) and secondary outcomes included change in the proportion of patients meeting diabetes quality indicators: blood pressure control, statin use, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACEi/ARB) use, and annual microalbuminuria testing. Key Results Our propensity-matched cohort included 9010 patients split evenly between those who participated in V-IMPACT and those who remained in usual in-person care. Among individuals with diabetes who participated in V-IMPACT, the change in mean HbA1C was − 0.055% (95% CI − 0.088 to − 0.022%) while those in usual care had a − 0.047% (95% CI − 0.080 to − 0.014%) change before and after program implementation. We observed a 5.1% (95% CI 2.4 to 7.7%) absolute increase in the proportion prescribed statins in the V-IMPACT group, a 5.3% (95% CI 2.5 to 8.2%) increase prescribed ACE/ARBs, and a 4.6% (95% 1.7 to 7.5%) increase in completed yearly microalbuminuria testing. V-IMPACT was not associated with a significant difference in the proportion with controlled blood pressure at < 140/90 or < 130/90 mmHg thresholds. Conclusions Quality of diabetes care delivered by a longitudinal virtual primary care model was similar if not better than traditional in-person care.
doi_str_mv 10.1007/s11606-020-06547-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7822396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480460355</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-8e6616525123c62fd6e531bfd4b9a7e30f79b6dc305d4bf8ad8420b82a0ac1753</originalsourceid><addsrcrecordid>eNp9UclO5DAQtRAIGpgf4IAicZlLmPLuXJBQMyxSSzDSMFfLSZzGKB03doKav8dNWAYOnEryW-qVH0IHGI4xgPwVMRYgciCQg-BM5qsNNMGc8ByzQm6iCSjFciUp20G7Md4DYEqI2kY7lDJFFeYTdHG1WJqqz3yTzXw3d_1Qu8602T8X-iHNm-AWJjxlUxNs5rvszJnS9jZmfxLq-qe1cI3to63GtNH-eJ176Pb899_pZT67vrians7yiknW58oKgUWKiAmtBGlqYTnFZVOzsjDSUmhkUYq6osDTU6NMrRiBUhEDpsKS0z10Mvouh3Jh68p2fTCtXo4xtTdOf0Y6d6fn_lFLRQgtRDL4-WoQ_MNgY68XLla2bU1n_RA1YQqYAMrXu46-UO_9ENLvJBYXTBSKYUgsMrKq4GMMtnkPg0Gve9JjTzr1pF960qskOvz_jHfJWzGJQEdCTFA3t-Fj9ze2zwSqnh0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2564698410</pqid></control><display><type>article</type><title>Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care</title><source>SpringerNature Complete Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Lu, Amy D. ; Gunzburger, Elise ; Glorioso, Thomas J. ; Smith, William B. ; Kenney, Rachael R. ; Whooley, Mary A. ; Ho, P. Michael</creator><creatorcontrib>Lu, Amy D. ; Gunzburger, Elise ; Glorioso, Thomas J. ; Smith, William B. ; Kenney, Rachael R. ; Whooley, Mary A. ; Ho, P. Michael</creatorcontrib><description>Background Lack of healthcare access to due to physician shortages is a significant driver of telemedicine expansion in rural areas. Telemedicine is effective for management of chronic conditions such as diabetes but its effectiveness in primary care settings is unknown. Objective To evaluate differences in diabetes care before and after implementation of a longitudinal virtual primary care program. Design Propensity score-matched cohort study utilizing difference-in-differences analysis. Participants Patients with diabetes who received care at VA primary care clinics between January 2018 and December 2019 where the Virtual Integrated Multisite Patient Aligned Care Teams (V-IMPACT) program was implemented. Exposure Patient participation in at least one V-IMPACT visit while usual care patients did not participate in V-IMPACT. Main Measures The primary outcome was change in hemoglobin A1C (HbA1C) and secondary outcomes included change in the proportion of patients meeting diabetes quality indicators: blood pressure control, statin use, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACEi/ARB) use, and annual microalbuminuria testing. Key Results Our propensity-matched cohort included 9010 patients split evenly between those who participated in V-IMPACT and those who remained in usual in-person care. Among individuals with diabetes who participated in V-IMPACT, the change in mean HbA1C was − 0.055% (95% CI − 0.088 to − 0.022%) while those in usual care had a − 0.047% (95% CI − 0.080 to − 0.014%) change before and after program implementation. We observed a 5.1% (95% CI 2.4 to 7.7%) absolute increase in the proportion prescribed statins in the V-IMPACT group, a 5.3% (95% CI 2.5 to 8.2%) increase prescribed ACE/ARBs, and a 4.6% (95% 1.7 to 7.5%) increase in completed yearly microalbuminuria testing. V-IMPACT was not associated with a significant difference in the proportion with controlled blood pressure at &lt; 140/90 or &lt; 130/90 mmHg thresholds. Conclusions Quality of diabetes care delivered by a longitudinal virtual primary care model was similar if not better than traditional in-person care.</description><identifier>ISSN: 0884-8734</identifier><identifier>EISSN: 1525-1497</identifier><identifier>DOI: 10.1007/s11606-020-06547-x</identifier><identifier>PMID: 33483815</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Angiotensin ; Angiotensin II ; Angiotensin-converting enzyme inhibitors ; Blood pressure ; Chronic conditions ; Chronic illnesses ; Diabetes ; Diabetes mellitus ; Enzyme inhibitors ; Health care ; Hemoglobin ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Original Research ; Patients ; Peptidyl-dipeptidase A ; Primary care ; Quality of care ; Rural areas ; Statins ; Telemedicine</subject><ispartof>Journal of general internal medicine : JGIM, 2021-09, Vol.36 (9), p.2585-2592</ispartof><rights>Society of General Internal Medicine 2021</rights><rights>Society of General Internal Medicine 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-8e6616525123c62fd6e531bfd4b9a7e30f79b6dc305d4bf8ad8420b82a0ac1753</citedby><cites>FETCH-LOGICAL-c474t-8e6616525123c62fd6e531bfd4b9a7e30f79b6dc305d4bf8ad8420b82a0ac1753</cites><orcidid>0000-0002-6028-299X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822396/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822396/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41488,42557,51319,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33483815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Amy D.</creatorcontrib><creatorcontrib>Gunzburger, Elise</creatorcontrib><creatorcontrib>Glorioso, Thomas J.</creatorcontrib><creatorcontrib>Smith, William B.</creatorcontrib><creatorcontrib>Kenney, Rachael R.</creatorcontrib><creatorcontrib>Whooley, Mary A.</creatorcontrib><creatorcontrib>Ho, P. Michael</creatorcontrib><title>Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care</title><title>Journal of general internal medicine : JGIM</title><addtitle>J GEN INTERN MED</addtitle><addtitle>J Gen Intern Med</addtitle><description>Background Lack of healthcare access to due to physician shortages is a significant driver of telemedicine expansion in rural areas. Telemedicine is effective for management of chronic conditions such as diabetes but its effectiveness in primary care settings is unknown. Objective To evaluate differences in diabetes care before and after implementation of a longitudinal virtual primary care program. Design Propensity score-matched cohort study utilizing difference-in-differences analysis. Participants Patients with diabetes who received care at VA primary care clinics between January 2018 and December 2019 where the Virtual Integrated Multisite Patient Aligned Care Teams (V-IMPACT) program was implemented. Exposure Patient participation in at least one V-IMPACT visit while usual care patients did not participate in V-IMPACT. Main Measures The primary outcome was change in hemoglobin A1C (HbA1C) and secondary outcomes included change in the proportion of patients meeting diabetes quality indicators: blood pressure control, statin use, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACEi/ARB) use, and annual microalbuminuria testing. Key Results Our propensity-matched cohort included 9010 patients split evenly between those who participated in V-IMPACT and those who remained in usual in-person care. Among individuals with diabetes who participated in V-IMPACT, the change in mean HbA1C was − 0.055% (95% CI − 0.088 to − 0.022%) while those in usual care had a − 0.047% (95% CI − 0.080 to − 0.014%) change before and after program implementation. We observed a 5.1% (95% CI 2.4 to 7.7%) absolute increase in the proportion prescribed statins in the V-IMPACT group, a 5.3% (95% CI 2.5 to 8.2%) increase prescribed ACE/ARBs, and a 4.6% (95% 1.7 to 7.5%) increase in completed yearly microalbuminuria testing. V-IMPACT was not associated with a significant difference in the proportion with controlled blood pressure at &lt; 140/90 or &lt; 130/90 mmHg thresholds. Conclusions Quality of diabetes care delivered by a longitudinal virtual primary care model was similar if not better than traditional in-person care.</description><subject>Angiotensin</subject><subject>Angiotensin II</subject><subject>Angiotensin-converting enzyme inhibitors</subject><subject>Blood pressure</subject><subject>Chronic conditions</subject><subject>Chronic illnesses</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Enzyme inhibitors</subject><subject>Health care</subject><subject>Hemoglobin</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Original Research</subject><subject>Patients</subject><subject>Peptidyl-dipeptidase A</subject><subject>Primary care</subject><subject>Quality of care</subject><subject>Rural areas</subject><subject>Statins</subject><subject>Telemedicine</subject><issn>0884-8734</issn><issn>1525-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9UclO5DAQtRAIGpgf4IAicZlLmPLuXJBQMyxSSzDSMFfLSZzGKB03doKav8dNWAYOnEryW-qVH0IHGI4xgPwVMRYgciCQg-BM5qsNNMGc8ByzQm6iCSjFciUp20G7Md4DYEqI2kY7lDJFFeYTdHG1WJqqz3yTzXw3d_1Qu8602T8X-iHNm-AWJjxlUxNs5rvszJnS9jZmfxLq-qe1cI3to63GtNH-eJ176Pb899_pZT67vrians7yiknW58oKgUWKiAmtBGlqYTnFZVOzsjDSUmhkUYq6osDTU6NMrRiBUhEDpsKS0z10Mvouh3Jh68p2fTCtXo4xtTdOf0Y6d6fn_lFLRQgtRDL4-WoQ_MNgY68XLla2bU1n_RA1YQqYAMrXu46-UO_9ENLvJBYXTBSKYUgsMrKq4GMMtnkPg0Gve9JjTzr1pF960qskOvz_jHfJWzGJQEdCTFA3t-Fj9ze2zwSqnh0</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Lu, Amy D.</creator><creator>Gunzburger, Elise</creator><creator>Glorioso, Thomas J.</creator><creator>Smith, William B.</creator><creator>Kenney, Rachael R.</creator><creator>Whooley, Mary A.</creator><creator>Ho, P. Michael</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6028-299X</orcidid></search><sort><creationdate>20210901</creationdate><title>Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care</title><author>Lu, Amy D. ; Gunzburger, Elise ; Glorioso, Thomas J. ; Smith, William B. ; Kenney, Rachael R. ; Whooley, Mary A. ; Ho, P. Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-8e6616525123c62fd6e531bfd4b9a7e30f79b6dc305d4bf8ad8420b82a0ac1753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Angiotensin</topic><topic>Angiotensin II</topic><topic>Angiotensin-converting enzyme inhibitors</topic><topic>Blood pressure</topic><topic>Chronic conditions</topic><topic>Chronic illnesses</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Enzyme inhibitors</topic><topic>Health care</topic><topic>Hemoglobin</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Original Research</topic><topic>Patients</topic><topic>Peptidyl-dipeptidase A</topic><topic>Primary care</topic><topic>Quality of care</topic><topic>Rural areas</topic><topic>Statins</topic><topic>Telemedicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Amy D.</creatorcontrib><creatorcontrib>Gunzburger, Elise</creatorcontrib><creatorcontrib>Glorioso, Thomas J.</creatorcontrib><creatorcontrib>Smith, William B.</creatorcontrib><creatorcontrib>Kenney, Rachael R.</creatorcontrib><creatorcontrib>Whooley, Mary A.</creatorcontrib><creatorcontrib>Ho, P. Michael</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of general internal medicine : JGIM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Amy D.</au><au>Gunzburger, Elise</au><au>Glorioso, Thomas J.</au><au>Smith, William B.</au><au>Kenney, Rachael R.</au><au>Whooley, Mary A.</au><au>Ho, P. Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care</atitle><jtitle>Journal of general internal medicine : JGIM</jtitle><stitle>J GEN INTERN MED</stitle><addtitle>J Gen Intern Med</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>36</volume><issue>9</issue><spage>2585</spage><epage>2592</epage><pages>2585-2592</pages><issn>0884-8734</issn><eissn>1525-1497</eissn><abstract>Background Lack of healthcare access to due to physician shortages is a significant driver of telemedicine expansion in rural areas. Telemedicine is effective for management of chronic conditions such as diabetes but its effectiveness in primary care settings is unknown. Objective To evaluate differences in diabetes care before and after implementation of a longitudinal virtual primary care program. Design Propensity score-matched cohort study utilizing difference-in-differences analysis. Participants Patients with diabetes who received care at VA primary care clinics between January 2018 and December 2019 where the Virtual Integrated Multisite Patient Aligned Care Teams (V-IMPACT) program was implemented. Exposure Patient participation in at least one V-IMPACT visit while usual care patients did not participate in V-IMPACT. Main Measures The primary outcome was change in hemoglobin A1C (HbA1C) and secondary outcomes included change in the proportion of patients meeting diabetes quality indicators: blood pressure control, statin use, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACEi/ARB) use, and annual microalbuminuria testing. Key Results Our propensity-matched cohort included 9010 patients split evenly between those who participated in V-IMPACT and those who remained in usual in-person care. Among individuals with diabetes who participated in V-IMPACT, the change in mean HbA1C was − 0.055% (95% CI − 0.088 to − 0.022%) while those in usual care had a − 0.047% (95% CI − 0.080 to − 0.014%) change before and after program implementation. We observed a 5.1% (95% CI 2.4 to 7.7%) absolute increase in the proportion prescribed statins in the V-IMPACT group, a 5.3% (95% CI 2.5 to 8.2%) increase prescribed ACE/ARBs, and a 4.6% (95% 1.7 to 7.5%) increase in completed yearly microalbuminuria testing. V-IMPACT was not associated with a significant difference in the proportion with controlled blood pressure at &lt; 140/90 or &lt; 130/90 mmHg thresholds. Conclusions Quality of diabetes care delivered by a longitudinal virtual primary care model was similar if not better than traditional in-person care.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>33483815</pmid><doi>10.1007/s11606-020-06547-x</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6028-299X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-8734
ispartof Journal of general internal medicine : JGIM, 2021-09, Vol.36 (9), p.2585-2592
issn 0884-8734
1525-1497
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7822396
source SpringerNature Complete Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Angiotensin
Angiotensin II
Angiotensin-converting enzyme inhibitors
Blood pressure
Chronic conditions
Chronic illnesses
Diabetes
Diabetes mellitus
Enzyme inhibitors
Health care
Hemoglobin
Internal Medicine
Medicine
Medicine & Public Health
Original Research
Patients
Peptidyl-dipeptidase A
Primary care
Quality of care
Rural areas
Statins
Telemedicine
title Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A01%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Longitudinal%20Virtual%20Primary%20Care%20on%20Diabetes%20Quality%20of%20Care&rft.jtitle=Journal%20of%20general%20internal%20medicine%20:%20JGIM&rft.au=Lu,%20Amy%20D.&rft.date=2021-09-01&rft.volume=36&rft.issue=9&rft.spage=2585&rft.epage=2592&rft.pages=2585-2592&rft.issn=0884-8734&rft.eissn=1525-1497&rft_id=info:doi/10.1007/s11606-020-06547-x&rft_dat=%3Cproquest_pubme%3E2480460355%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2564698410&rft_id=info:pmid/33483815&rfr_iscdi=true